Glasdegib in combination with low-dose Cytarabine for the outpatient treatment of relapsed or refractory acute myeloid leukemia in unfit patients
Andrius Žučenka, Kazimieras Maneikis, Birute Pugaciute, Ugnė Ringelevičiūtė, Austėja Dapkevičiūtė, Linas Davainis, Guoda Daukėlaitė, Paulina Burzdikaitė, Vytautas Staras, Laimonas Griškevičius
Topics & Concepts
CytarabineMedicineMyeloid leukemiaRefractory (planetary science)Internal medicineHematologyOncologyLeukemiaIntensive care medicineBiologyAstrobiologyAcute Myeloid Leukemia ResearchHedgehog Signaling Pathway StudiesAcute Lymphoblastic Leukemia research